WallStreetZenWallStreetZen

NYSEMKT: PLX
Protalix Biotherapeutics Inc Stock Ownership - Who owns Protalix Biotherapeutics?

Insider buying vs selling

Have Protalix Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Dror BashanPRESIDENT AND CEO2023-10-1916,129$1.41
$22.74kBuy
Dror BashanPRESIDENT AND CEO2023-10-1948,387$1.40
$67.74kBuy

1 of 1

PLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLX insiders and whales buy or sell their stock.

PLX Shareholders

What type of owners hold Protalix Biotherapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Biocell Ltd41.52%30,442,586$35.62MInsider
Phillip Md Et Al Frost24.80%18,184,566$21.28MInsider
Zeev Bronfeld22.68%16,628,800$19.46MInsider
Eyal Sheratzki19.73%14,466,319$16.93MInsider
Camber Capital Management LP14.70%10,775,000$12.61MInsider
Sharon Toussiacohen8.94%6,556,381$7.67MInsider
Marathon Investments Ltd8.94%6,556,381$7.67MInsider
Amos Barshalev8.44%6,187,726$7.24MInsider
Technorov Holdings 1993 Ltd8.44%6,186,046$7.24MInsider
Eli Hurvitz7.30%5,353,923$6.26MInsider

1 of 3

PLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PLX6.39%93.61%Net Buying
ONCY1.78%0.00%
CUE33.69%9.31%Net Buying
VTVT0.55%99.45%Net BuyingNet Buying
SLS13.29%13.12%Net Selling

Protalix Biotherapeutics Stock Ownership FAQ

Who owns Protalix Biotherapeutics?

Protalix Biotherapeutics (NYSEMKT: PLX) is owned by 12.67% institutional shareholders, 185.58% Protalix Biotherapeutics insiders, and 0.00% retail investors. Biocell Ltd is the largest individual Protalix Biotherapeutics shareholder, owning 30.44M shares representing 41.52% of the company. Biocell Ltd's Protalix Biotherapeutics shares are currently valued at $34.70M.

If you're new to stock investing, here's how to buy Protalix Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.